New products face long timelines, costly trials, and pressure from investors. Delays in development or poor scaling can result in significant financial losses. ILSC helps life sciences companies design, test, and scale products that are ready for both the lab and the market.
Faster, Aligned R&D
Move forward with clear preclinical and clinical pathways, IP protection, and integration with Sales & Operations Planning (S&OP).
Fewer Failed Batches
Predict stability, performance, and manufacturability months in advance with QbD-based formulation risk based design and predictive AI models.
Scalable Processes from Day One
Cut wasted time and costs by building efficient manufacturing processes for solids, semi-solids, and liquids with lean practices.
ILSC combines regulatory, scientific, and operational expertise with predictive tools so you launch faster and with fewer setbacks.
Every month lost in development increases costs and delays revenue. Acting early prevents expensive rework later.